The early days of NK cells: An example of how a phenomenon led to detection of a novel immune receptor system - lessons from a rat model

Frontiers in Immunology

Volumn 5, Issue JUN, 2014, Pages

  Rolstad, Bent ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Activating receptors; Inhibitory receptors; Ly49 receptors; MHC I molecules; Natural killer cells; NK receptor repertoire; Rat models; Rat NK alloreactivity

Indexed keywords

EID: 84905669525     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00283     Document Type: Review

References (87)

1. Kiessling R, Klein E, Wigzell H. "Natural" killer cells in the mouse I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol (1975) 5:112-7. doi:10.1002/eji.1830050208
2. Kiessling R, Klein E, Pross H, Wigzell H. "Natural" killer cells in the mouse II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol (1975) 5:117-21. doi:10.1002/eji.1830050208
3. Herberman RB, Nunn ME, Holden HT, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer (1975) 16:230-9. doi:10.1002/ijc.2910160205
4. Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer (1975) 16:216-29. doi:10.1002/ijc.2910160205
5. Cudkowicz G, Stimpfling JH. Hybrid resistance to parental marrow grafts: association with the K region of H-2. Science (1964) 144:1339-40. doi:10.1126/science.144.3624.1339
6. Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med (1971) 134:83-102. doi:10.1084/jem.134.1.83
7. Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F1 hybrid mice. J Exp Med (1971) 134:1513-28. doi:10.1084/jem.134.1.83
8. Bennett M. Rejection of marrow allografts. Importance of H-2 homozygosity of donor cells. Transplantation (1972) 14:289-98. doi:10.1097/00007890-197209000-00001
9. Kiessling R, Hochman PS, Haller O, Shearer GM, Wigzell H, Cudkowicz G. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol (1977) 7:655-63. doi:10.1002/eji.1830070915
10. Kärre K. Role of target histocompatibility antigens in regulation of natural killer activity: a reevaluation and a hypothesis. In: Herberman RB, Callewaert DM, editors. Mechanisms of Cytotoxicity by NK Cells. Orlando: Academic Press (1985). p. 81-92.
11. Kärre K, Ljunggren H-G, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature (1986) 319:675-8. doi:10.1038/319675a0
12. Ljunggren H-G, Kärre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 11:237-44. doi:10.1016/0167-5699(90)90097-S
13. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science (1999) 285:727-9. doi:10.1126/science.285.5428.727
14. Beilke JN, Benjamin J, Lanier LL. The requirement for NKG2D in NK cell-mediated rejection of parental bone marrow grafts is determined by inhibitory receptors for MHC class I expressed by the graft recipient. Blood (2010) 116(24):5208-16. doi:10.1182/blood-2010-05-285031
15. Rolstad B. The influence of strong transplantation antigens (Ag-B) on lymphocyte migration in vivo. Cell Immunol (1979) 45:389-97. doi:10.1016/0008-8749(79)90399-X
16. McNeilage LJ, Heslop BF. Lymphocyte homing in syngeneic and unsensitized MHC compatible allogeneic hosts I. Evidence for both syngeneic self-recognition and early killing of allogeneic cells. Cell Immunol (1980) 50:58-70. doi:10.1016/0008-8749(80)90006-4
17. Ager A, Fajumi J, Sparshott SM, Ford WL, Butcher GW. Major histocompatibility complex control of NK-related allogeneic lymphocyte cytotoxicity in rats. Transplantation (1988) 46:762-7. doi:10.1097/00007890-198811000-00025
18. McNeilage LJ, Heslop BF, Heyworth MR, Gutman GA. Natural cytotoxicity in rats: strain distribution and genetics. Cell Immunol (1982) 72:340-50. doi:10.1016/0008-8749(82)90482-8
19. Heslop BF, McNeilage LJ. Natural cytotoxicity: early killing of allogeneic lymphocytes in rats. Immunol Rev (1983) 73:35-51. doi:10.1111/j.1600-065X.1983.tb01077.x
20. Fossum S, Rolstad B. The roles of interdigitating cells and natural killer cells in the rapid rejection of allogeneic lymphocytes. Eur J Immunol (1986) 16:440-50. doi:10.1002/eji.1830160422
21. Rolstad B, Ford WL. The rapid elimination of allogeneic lymphocytes: relationship to established mechanisms of immunity and to lymphocyte traffic. Immunol Rev (1983) 73:87-113. doi:10.1111/j.1600-065X.1983.tb01080.x
22. Rolstad B. Allogeneic and semiallogeneic immunizations with a strong transplantation antigen (Ag-B). Transplantation (1977) 23:248-54. doi:10.1097/00007890-197703000-00007
23. Zatz MM, Gingrich R, Lance EM. The effect of histocompatibility antigens on lymphocyte migration in the mouse. Immunology (1972) 23:665-75.
24. Degos L, Pla M, Colombani M. H-2 restriction for lymphocyte homing into lymph nodes. Eur J Immunol (1979) 9:808-14. doi:10.1002/eji.1830091012
25. Gowans JL. The recirculation of lymphocytes from blood to lymph in the rat. J Physiol (1959) 140:54-69.
26. Gowans JL, Knight EJ. The route of recirculation of lymphocytes in the rat. Proc R Soc Lond B Biol Sci (1964) 159:257-82. doi:10.1098/rspb.1964.0001
27. Ford WL, Gowans JL. The traffic of lymphocytes. [Review]. Semin Hematol (1969) 6:67-83.
28. Tønnesen B, Rolstad B. In vivo elimination of allogeneic lymphocytes in normal and T-cell-deficient rats. Elimination does not require T cells. Scand J Immunol (1983) 17:303-12. doi:10.1111/j.1365-3083.1983.tb00794.x
29. Rolstad B, Fossum S, Bazin H, Kimber I, Marshall J, Sparshott SM, et al. The rapid rejection of allogeneic lymphocytes by a non-adaptive, cell-mediated mechanism (NK activity). Immunology (1985) 54:127-38.
30. Fossum S, Ager A, Rolstad B. Specific inhibition of natural killer (NK) activity against different alloantigens. Immunogenetics (1987) 26:329-38. doi:10.1007/BF00343700
31. Vaage JT, Dissen E, Ager A, Fossum S, Rolstad B. Allospecific recognition of hemic cells in vitro by natural killer cells from athymic rats: evidence that allodeterminants coded for by single major histocompatibility complex haplotypes are recognized. Eur J Immunol (1991) 21:2167-75. doi:10.1002/eji.1830210927
32. Vaage JT, Naper C, Løvik G, Lambracht D, Rehm A, Hedrich HJ, et al. Control of rat natural killer cell-mediated allorecognition by a major histocompatibility complex region encoding nonclassical class I antigens. J Exp Med (1994) 180:641-51. doi:10.1084/jem.180.2.641
33. Günther E, Wurst W. Cytotoxic T lymphocytes of the rat are predominantly restricted by RT1.A and not RT1.C-determined major histocompatibility class I antigens. Immunogenetics (1984) 20:1-12. doi:10.1007/BF00373442
34. Naper C, Rolstad B, Wonigeit K, Butcher GW, Vaage JT. Genes in two MHC class I regions control recognition of a single rat natural killer cell allodeterminant. Int Immunol (1996) 8:1779-85. doi:10.1093/intimm/8.11.1779
35. Rolstad B, Vaage JT, Naper C, Lambracht D, Wonigeit K, Joly E, et al. Positive and negative MHC class I recognition by rat NK cells. Immunol Rev (1997) 155:91-104. doi:10.1111/j.1600-065X.1997.tb00942.x
36. Rolstad B, Naper C, Løvik G, Vaage JT, Ryan JC, Backman-Petersson E, et al. Rat NK cell receptor systems and recognition of MHC-I molecules. Immunol Rev (2001) 181:149-57. doi:10.1034/j.1600-065X.2001.1810112.x
37. Klein J, Figueroa F. Evolution of the major histocompatibility complex. Crit Rev Immunol (1986) 6:295-386.
38. Walter L, Günther E. Physical mapping and evolution of the centromeric class I gene-containing region of the rat MHC. Immunogenetics (2000) 51:829-37. doi:10.1007/s002510000219
39. Ioannidu S, Walter L, Dressel R, Gunther E. Physical map and expression profile of genes of the telomeric class I gene region of the rat MHC. J Immunol (2001) 166:3957-65. doi:10.4049/jimmunol.166.6.3957
40. Rolstad B, Wonigeit K, Vaage JT. Alloreactive rat natural killer (NK) cells in vivo and in vitro: the role of the major histocompatibility complex (MHC). In: Rolstad B, editor. Natural Immunity to Normal Hemopoietic Cells. Boca Raton: CRC Press, Inc (1994). p. 99-149.
41. Rolstad B, Fossum S. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC. Immunology (1987) 60:151-7.
42. Naper C, Vaage JT, Lambracht D, Løvik G, Butcher GW, Wonigeit K, et al. Alloreactive natural killer cells in the rat. Complex genetics of MHC control. Eur J Immunol (1995) 25:1249-56. doi:10.1002/eji.1830250518
43. Moretta A, Tambussi G, Bottino C, Tripodi G, Merli A, Ciccone E, et al. A novel surface antigen expressed by a subset of human CD3-CD16+ natural killer cells. J Exp Med (1990) 171:695-714. doi:10.1084/jem.171.3.695
44. Moretta A, Bottino C, Pende D, Tripodi G, Tambussi G, Viale O, et al. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med (1990) 172:1589-98. doi:10.1084/jem.172.6.1589
45. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med (1995) 182:875-84. doi:10.1084/jem.182.3.875
46. Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol (1993) 11:613-35. doi:10.1146/annurev.immunol.11.1.613
47. Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature (1992) 358:66-70. doi:10.1038/358066a0
48. Karlhofer FM, Ribaudo RK, Yokoyama WM. The interaction of Ly-49 with H-2Dd globally inactivates natural killer cell cytolytic activity. Trans Assoc Am Physicians (1992) 105:72-85.
49. Dissen E, Ryan JC, Seaman WE, Fossum S. An autosomal dominant locus, Nka, mapping to the Ly-49 region of a rat natural killer (NK) gene complex, controls NK cell lysis of allogeneic lymphocytes. J Exp Med (1996) 183:2197-207. doi:10.1084/jem.183.5.2197
50. Naper C, Ryan JC, Nakamura MC, Lambracht D, Rolstad B, Vaage JT. Identification of an inhibitory MHC receptor on alloreactive rat NK cells. J Immunol (1998) 160:219-24.
51. Naper C, Hayashi S, Joly E, Butcher GW, Rolstad B, Vaage JT, et al. Ly49i2 is an inhibitory rat natural killer cell receptor for an MHC class Ia molecule (RT1-A1c). Eur J Immunol (2002) 32:2031-6. doi:10.1002/1521-4141(200207)32:7<2031::AID-IMMU2031>3.0.CO;2-H
52. Naper C, Hayashi S, Kveberg L, Niemi EC, Lanier LL, Vaage JT, et al. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands. J Immunol (2002) 169:22-30. doi:10.4049/jimmunol.169.1.22
53. Kveberg L, Dai KZ, Dissen E, Ryan JC, Rolstad B, Vaage JT, et al. Strain-dependent expression of four structurally related rat Ly49 receptors; correlation with NK gene complex haplotype and NK alloreactivity. Immunogenetics (2006) 58:905-16. doi:10.1007/s00251-006-0154-x
54. Naper C, Dai KZ, Kveberg L, Rolstad B, Niemi EC, Vaage JT, et al. Two structurally related rat Ly49 receptors with opposing functions (Ly49 stimulatory receptor 5 and Ly49 inhibitory receptor 5) recognize nonclassical MHC class Ib-encoded target ligands. J Immunol (2005) 174:2702-11. doi:10.4049/jimmunol.174.5.2702
55. Nakamura MC, Niemi EC, Fisher MJ, Schultz LD, Seaman WE, Ryan JC. Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phophatase. J Exp Med (1997) 185:673-84. doi:10.1084/jem.185.4.673
56. George TC, Ortaldo JR, Lemieux S, Kumar V, Bennett M. Tolerance and alloreactivity of the Ly49D subset of murine NK cells. J Immunol (1999) 163:1859-67.
57. Nylenna O, Naper C, Vaage JT, Woon PY, Gauguier D, Dissen E, et al. The genes and gene organization of the Ly49 region of the rat natural killer cell gene complex. Eur J Immunol (2005) 35:261-72. doi:10.1002/eji.200425429
58. Hamerman JA, Tchao NK, Lowell CA, Lanier LL. Enhanced toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol (2005) 6:579-86. doi:10.1038/ni1204
59. Shegarfi H, Sydnes K, Lovik M, Inngjerdingen M, Rolstad B, Naper C. The role of natural killer cells in resistance to the intracellular bacterium Listeria monocytogenes in rats. Scand J Immunol (2009) 70:238-44. doi:10.1111/j.1365-3083.2009.02292.x
60. Shegarfi H, Dai KZ, Inngjerdingen M, Ryan JC, Vaage JT, Rolstad B, et al. The activating rat Ly49s5 receptor responds to increased levels of MHC class Ib molecules on Listeria monocytogenes-infected enteric epithelial cells. Eur J Immunol (2010) 40:3535-43. doi:10.1002/eji.201040651
61. Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, et al. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med (1996) 183:645-50. doi:10.1084/jem.183.2.645
62. Abi-Rached L, Parham P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med (2005) 201:1319-32. doi:10.1084/jem.20042558
63. Akkaya M, Barclay AN. How do pathogens drive the evolution of paired receptors? Eur J Immunol (2013) 43:303-13. doi:10.1002/eji.201242896
64. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science (2002) 296:1323-6. doi:10.1126/science.1070884
65. Stewart CA, Laugier-Anfossi F, Vely F, Saulquin X, Riedmuller J, Tisserant A, et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A (2005) 102:13224-9. doi:10.1073/pnas.0503594102
66. Fossum S, Saether PC, Vaage JT, Daws MR, Dissen E. Paired opposing leukocyte receptors recognizing rapidly evolving ligands are subject to homogenization of their ligand binding domains. Immunogenetics (2011) 63:809-20. doi:10.1007/s00251-011-0553-5
67. George TC, Mason LH, Ortaldo JR, Kumar V, Bennett M. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J Immunol (1999) 162:2035-43.
68. Pittari G, Liu XR, Selvakumar A, Zhao Z, Merino E, Huse M, et al. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand. J Immunol (2013) 190:4650-60. doi:10.4049/jimmunol.1202120
69. Hilton HG, Vago L, Older Aguilar AM, Moesta AK, Graef T, Abi-Rached L, et al. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3. J Immunol (2012) 189:1418-30. doi:10.4049/jimmunol.1100431
70. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature (2005) 436:709-13. doi:10.1038/nature03847
71. Petersson E, Holmdahl R, Butcher GW, Hedlund G. Activation and selection of NK cells via recognition of an allogeneic, non-classical MHC class I molecule, RT1-E. Eur J Immunol (1999) 29:3663-73. doi:10.1002/(SICI)1521-4141(199911)29:11<3663::AID-IMMU3663>3.3.CO;2-6
72. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature (2009) 457:557-61. doi:10.1038/nature07665
73. Nordquist N, Olofsson P, Vingsbo-Lundberg C, Petterson U, Holmdahl R. Complex genetic control in a rat model for rheumatoid arthritis. J Autoimmun (2000) 15:425-32. doi:10.1006/jaut.2000.0450
74. Lorentzen JC, Glaser A, Jacobsson L, Galli J, Fakhrai-rad H, Klareskog L, et al. Identification of rat susceptibility loci for adjuvant-oil-induced arthritis. Proc Natl Acad Sci U S A (1998) 95:6383-7. doi:10.1073/pnas.95.11.6383
75. Rao SS, Ranganath Pai KS, Potu BK, Bhat KM. Beneficial effect of Cissus quadrangularis Linn. on osteopenia associated with streptozotocin-induced type 1 diabetes mellitus in male Wistar rats. Adv Pharmacol Sci (2014) 2014:483051. doi:10.1155/2014/483051
76. Wallis RH, Wang K, Marandi L, Hsieh E, Ning T, Chao GY, et al. Type 1 diabetes in the BB rat: a polygenic disease. Diabetes (2009) 58:1007-17. doi:10.2337/db08-1215
77. Cui SL, Yu J, Shoujun L. Iodine intake increases IP-10 expression in the serum and thyroids of rats with experimental autoimmune thyroiditis. Int J Endocrinol (2014) 2014:581069. doi:10.1155/2014/581069
78. Sedgwick J, Brostoff S, Mason D. Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system. J Exp Med (1987) 165:1058-75. doi:10.1084/jem.165.4.1058
79. Brostoff SW, Mason DW. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J Immunol (1984) 133:1938-42.
80. Engh E, Benestad HB, Strøm-Gundersen I, Vaage JT, Bell EB, Rolstad B. The role of classical (RT1.A) and nonclassical (RT1.C) MHC class I regions in NK cell mediated bone marrow allograft rejection in rats. Transplantation (1998) 65:319-24. doi:10.1097/00007890-199802150-00005
81. Engh E, Strøm-Gundersen I, Benestad HB, Rolstad B. Long-term donor chimerism after MHC (RT1) mismatched bone marrow transplantation in the rat: the role of host alloreactive NK cells. Scand J Immunol (2001) 54:198-203. doi:10.1046/j.1365-3083.2001.00929.x
82. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (2002) 295:2097-100. doi:10.1126/science.1068440
83. Pende D, Marcenaro S, Falco M, Martini S, Bernardo ME, Montagna D, et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood (2009) 113:3119-29. doi:10.1182/blood-2008-06-164103
84. Sivori S, Carlomagno S, Falco M, Romeo E, Moretta L, Moretta A. Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT. Blood (2011) 117:4284-92. doi:10.1182/blood-2010-10-316125
85. Marcenaro E, Carlomagno S, Pesce S, Della CM, Moretta A, Sivori S. Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation. J Leukoc Biol (2011) 90:661-7. doi:10.1189/jlb.0311137
86. Martens AC, van Bekkum DW, Hagenbeek A. The BN acute myelocytic leukemia (BNML) (A rat model for studying human acute myelocytic leukemia (AML). Leukemia (1990) 4:241-7.
87. Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, et al. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease. Transplantation (2008) 85:102-11. doi:10.1097/01.tp.0000296856.53493.1f